Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Upexi, Inc.

Upexi, Inc. (GRVI) Stock Overview

Explore Upexi, Inc.’s financial performance, market position, analyst ratings, and future outlook.

GRVI●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.95
$0.35(7.61%)
U.S. Market is Open · 14:50

Upexi, Inc. (GRVI)

Meyka AI Score

Z

Key Financials

Market Cap88.9M
P/E Ratio-4.85
EPS (TTM)$0.19
ROE-2.54%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

GRVI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Upexi, Inc. (NASDAQ: GRVI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Upexi, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GRVI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Upexi, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.85 and a market capitalization of 88.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GRVI on the NASDAQ.

Price Performance (NASDAQ: GRVI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-5.53%
Year-to-Date (YTD) Change
N/A
1-Year Change
4.65%
3-Year Change
-11.61%
5-Year Change
-11.61%
All-Time (Max) Change
-11.61%

Contact Information

https://groveinc.io
701-353-5425
1710 Whitney Mesa Drive, Henderson, NV, 89014

Company Facts

1,220 Employees
IPO DateJun 24, 2021
CountryUS

Frequently Asked Questions